Lung cancer patients with diabetes appeared to have higher one-, two- and three-year survival rates compared with those without diabetes, a study in the Journal of Thoracic Oncology revealed. The researchers said lung cancer patients with diabetes should receive standard therapy despite the co-morbidity but that more studies are needed to back the findings.

Related Summaries